Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
Croce S, Ribeiro A, Brulard C, Noel JC, Amant F, Stoeckle E, Devouassoux-Shisheborah M, Floquet A, Arnould L, Guyon F, Mishellany F, Garbay D, Cuppens T, Zikan M, Leroux A, Frouin E, Duvillard P, Terrier P, Farre I, Valo I, MacGrogan GM, Chibon F. Croce S, et al. Among authors: brulard c. Mod Pathol. 2015 Jul;28(7):1001-10. doi: 10.1038/modpathol.2015.3. Epub 2015 May 1. Mod Pathol. 2015. PMID: 25932961 Free article.
Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Italiano A, Lagarde P, Brulard C, Terrier P, Laë M, Marques B, Ranchere-Vince D, Michels JJ, Trassard M, Cioffi A, Piperno-Neumann S, Chevreau C, Blay JY, Delcambre C, Isambert N, Penel N, Bay JO, Bonvalot S, Le Cesne A, Coindre JM, Chibon F. Italiano A, et al. Among authors: brulard c. Clin Cancer Res. 2013 Mar 1;19(5):1190-6. doi: 10.1158/1078-0432.CCR-12-2970. Epub 2013 Jan 17. Clin Cancer Res. 2013. PMID: 23329812
Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival.
Salas S, Brulard C, Terrier P, Ranchere-Vince D, Neuville A, Guillou L, Lae M, Leroux A, Verola O, Jean-Emmanuel K, Bonvalot S, Blay JY, Le Cesne A, Aurias A, Coindre JM, Chibon F. Salas S, et al. Among authors: brulard c. Clin Cancer Res. 2015 Sep 15;21(18):4194-200. doi: 10.1158/1078-0432.CCR-14-2910. Epub 2015 Apr 15. Clin Cancer Res. 2015. PMID: 25878329
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.
Lagarde P, Przybyl J, Brulard C, Pérot G, Pierron G, Delattre O, Sciot R, Wozniak A, Schöffski P, Terrier P, Neuville A, Coindre JM, Italiano A, Orbach D, Debiec-Rychter M, Chibon F. Lagarde P, et al. Among authors: brulard c. J Clin Oncol. 2013 Feb 10;31(5):608-15. doi: 10.1200/JCO.2012.46.0147. Epub 2013 Jan 14. J Clin Oncol. 2013. PMID: 23319690
Response to chemotherapy is not related to chromosome instability in synovial sarcoma.
Chakiba C, Lagarde P, Pissaloux D, Neuville A, Brulard C, Pérot G, Coindre JM, Terrier P, Ranchere-Vince D, Ferrari A, Collini P, Suurmeijer AJH, Blay JY, Terrisse SA, Piperno-Neumann S, Averous G, Bui B, Orbach D, Italiano A, Chibon F. Chakiba C, et al. Among authors: brulard c. Ann Oncol. 2014 Nov;25(11):2267-2271. doi: 10.1093/annonc/mdu362. Epub 2014 Jul 28. Ann Oncol. 2014. PMID: 25070544 Free PMC article.
Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.
Delespaul L, Lesluyes T, Pérot G, Brulard C, Lartigue L, Baud J, Lagarde P, Le Guellec S, Neuville A, Terrier P, Vince-Ranchère D, Schmidt S, Debant A, Coindre JM, Chibon F. Delespaul L, et al. Among authors: brulard c. Clin Cancer Res. 2017 Feb 1;23(3):857-867. doi: 10.1158/1078-0432.CCR-16-0290. Epub 2016 Aug 15. Clin Cancer Res. 2017. PMID: 27528700
RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
Lesluyes T, Pérot G, Largeau MR, Brulard C, Lagarde P, Dapremont V, Lucchesi C, Neuville A, Terrier P, Vince-Ranchère D, Mendez-Lago M, Gut M, Gut I, Coindre JM, Chibon F. Lesluyes T, et al. Among authors: brulard c. Eur J Cancer. 2016 Apr;57:104-11. doi: 10.1016/j.ejca.2015.12.027. Epub 2016 Feb 23. Eur J Cancer. 2016. PMID: 26916546
Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.
Lagarde P, Pérot G, Kauffmann A, Brulard C, Dapremont V, Hostein I, Neuville A, Wozniak A, Sciot R, Schöffski P, Aurias A, Coindre JM, Debiec-Rychter M, Chibon F. Lagarde P, et al. Among authors: brulard c. Clin Cancer Res. 2012 Feb 1;18(3):826-38. doi: 10.1158/1078-0432.CCR-11-1610. Epub 2011 Dec 13. Clin Cancer Res. 2012. PMID: 22167411
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.
Lartigue L, Neuville A, Lagarde P, Brulard C, Rutkowski P, Dei Tos P, Wardelmann E, Debiec-Rychter M, Italiano A, Coindre JM, Chibon F. Lartigue L, et al. Among authors: brulard c. Eur J Cancer. 2015 Jan;51(1):75-83. doi: 10.1016/j.ejca.2014.10.014. Epub 2014 Nov 6. Eur J Cancer. 2015. PMID: 25466504
25 results